[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_2954 

# __Limited data, efficacy__

## Category to which it belongs

* [The fragmented and non-interoperable nature of data and knowledge, along with the lack of bioinformatics tools and data integration, hinder effective data management and sharing, leading to limitations in analysis, communication, and decision-making.](https://github.com/mm80843/T3.5/blob/pages/PBNCategory/PBN__PBNCategory_71.md)

## Closest similar item

* [Absence of efficacy studies in clinical settings](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1359.md)
* [Data gaps, limited research effect](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1648.md)
* [Insufficient data for analysis](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_3351.md)
* [Lack of patient control over medical data](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2953.md)
* [Limited data](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2586.md)
* [Limited data and sample size](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2786.md)
* [Limited data, accuracy](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_3156.md)
* [Limited sample size in observational studies](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_3323.md)
* [Limited statistical significance](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_321.md)
* [Limited testing and treatment capabilities](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_814.md)

## Mitigations of this risk

* [Vaccine development and drug discovery](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_4204.md)

